Expanding our scientific advice service
We’re expanding our scientific advisory service, NICE Scientific Advice, to better support companies whose products may require managed access to the NHS. We’ll do this by involving a managed access subject matter expert from within NICE to collaborate on your project. Managed access data collection has an important role to play in supporting earlier patient access to innovative treatments that have the potential to be cost-effective, but for which there is significant uncertainty around our decision to recommend a treatment for use.
In future, if companies seeking scientific advice from NICE have technical questions around data collection requirements as part of a future managed access arrangement, they should include these questions in their briefing book. This service is available for standard scientific advice and joint advice projects with the Medicines and Healthcare products Regulatory Agency.